TuHURA Biosciences Inc. (HURA)
4.15
0.01 (0.24%)
At close: Apr 17, 2025, 3:59 PM
4.09
-1.43%
After-hours: Apr 17, 2025, 07:56 PM EDT
0.24% (1D)
| Bid | 4.06 |
| Market Cap | 181.27M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.03M |
| EPS (ttm) | -1.21 |
| PE Ratio (ttm) | -3.43 |
| Forward PE | -4.84 |
| Analyst | Buy |
| Ask | 4.15 |
| Volume | 117,436 |
| Avg. Volume (20D) | 226,979 |
| Open | 4.13 |
| Previous Close | 4.14 |
| Day's Range | 3.91 - 4.21 |
| 52-Week Range | 1.80 - 14.60 |
| Beta | 0.79 |
About HURA
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL....
Industry Biotechnology
Sector Healthcare
IPO Date Feb 22, 2013
Employees 19
Stock Exchange NASDAQ
Ticker Symbol HURA
Website http://www.tuhurabio.com
Analyst Forecast
According to 2 analyst ratings, the average rating for HURA stock is "Buy." The 12-month stock price forecast is $11.5, which is an increase of 177.11% from the latest price.
Stock Forecasts2 weeks ago
+19.59%
TuHURA Biosciences shares are trading higher on po...
Unlock content with
Pro Subscription
1 month ago
+15.7%
TuHURA Biosciences shares are trading higher after the company announced it acquired Kineta.
1 month ago · accessnewswire.com
TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH ConferenceLive webcast fireside chat on Tuesday, March 18th at 8:30 AM PT TAMPA, FL / ACCESS Newswire / March 10, 2025 / TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 registration-stage immuno-on...
